Aptinyx Inc. (APTX): Price and Financial Metrics
Aptinyx Inc. (APTX)
Today's Latest Price: $3.66 USD
Updated Jan 27 4:00pm
Add APTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
APTX Stock Summary
- APTX's went public 2.61 years ago, making it older than just 6.87% of listed US stocks we're tracking.
- The ratio of debt to operating expenses for Aptinyx Inc is higher than it is for about merely 0.52% of US stocks.
- With a price/sales ratio of 98.59, Aptinyx Inc has a higher such ratio than 96.22% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Aptinyx Inc are CYCN, HRTX, BLUE, RESN, and BCDA.
- APTX's SEC filings can be seen here. And to visit Aptinyx Inc's official web site, go to www.aptinyx.com.
APTX Stock Price Chart Interactive Chart >
APTX Price/Volume Stats
| Current price | $3.66 | 52-week high | $6.47 |
| Prev. close | $3.87 | 52-week low | $1.60 |
| Day low | $3.58 | Volume | 841,613 |
| Day high | $3.84 | Avg. volume | 901,713 |
| 50-day MA | $3.63 | Dividend yield | N/A |
| 200-day MA | $3.64 | Market Cap | 231.52M |
Aptinyx Inc. (APTX) Company Bio
Aptinyx Inc. develops therapeutics for neurological disorders. The company is focused on the development of drugs that interact with the NMDA receptor, and the company says it will use the funds to advance drugs for chronic pain, post-traumatic stress disorder (PTSD) and cognitive impairment in Parkinson’s disease. The company was founded in 2015 and is based in Evantson, Illinois.
Loading social stream, please wait...